Peter W Hunt1, Mary Carrington. 1. San Francisco General Hospital AIDS Division, University of California, San Francisco, California 94110, USA. phunt@php.ucsf.edu
Abstract
PURPOSE OF REVIEW: The purpose of this review is to highlight recent advances in our understanding of host genetic determinants of HIV pathogenesis and to provide a theoretical framework for interpreting these studies in the context of our evolving understanding of HIV immunopathogenesis. RECENT FINDINGS: The first genome-wide association analysis of host determinants of HIV pathogenesis and other recent studies evaluating the interaction between killer cell immunoglobulin-like receptors and human leukocyte antigen alleles have implicated both adaptive and innate immune responses in the control of HIV replication. Furthermore, genetic variation associated with the expression of CCR5 and its ligand have been strongly associated with both decreased susceptibility to HIV infection and delayed clinical progression, independent of their effects on viral replication, suggesting a potential role for CCR5 inhibitors as immune-based therapies in HIV disease. SUMMARY: Host factors associated with the control of HIV replication may help identify important targets for vaccine design, while those associated with delayed clinical progression provide targets for future immune-based therapies against HIV infection.
PURPOSE OF REVIEW: The purpose of this review is to highlight recent advances in our understanding of host genetic determinants of HIV pathogenesis and to provide a theoretical framework for interpreting these studies in the context of our evolving understanding of HIV immunopathogenesis. RECENT FINDINGS: The first genome-wide association analysis of host determinants of HIV pathogenesis and other recent studies evaluating the interaction between killer cell immunoglobulin-like receptors and human leukocyte antigen alleles have implicated both adaptive and innate immune responses in the control of HIV replication. Furthermore, genetic variation associated with the expression of CCR5 and its ligand have been strongly associated with both decreased susceptibility to HIV infection and delayed clinical progression, independent of their effects on viral replication, suggesting a potential role for CCR5 inhibitors as immune-based therapies in HIV disease. SUMMARY: Host factors associated with the control of HIV replication may help identify important targets for vaccine design, while those associated with delayed clinical progression provide targets for future immune-based therapies against HIV infection.
Authors: J W Mellors; A Muñoz; J V Giorgi; J B Margolick; C J Tassoni; P Gupta; L A Kingsley; J A Todd; A J Saah; R Detels; J P Phair; C R Rinaldo Journal: Ann Intern Med Date: 1997-06-15 Impact factor: 25.391
Authors: L Meyer; M Magierowska; J B Hubert; C Rouzioux; C Deveau; F Sanson; P Debre; J F Delfraissy; I Theodorou Journal: AIDS Date: 1997-09 Impact factor: 4.177
Authors: J Eugen-Olsen; A K Iversen; P Garred; U Koppelhus; C Pedersen; T L Benfield; A M Sorensen; T Katzenstein; E Dickmeiss; J Gerstoft; P Skinhøj; A Svejgaard; J O Nielsen; B Hofmann Journal: AIDS Date: 1997-03 Impact factor: 4.177
Authors: A M de Roda Husman; M Koot; M Cornelissen; I P Keet; M Brouwer; S M Broersen; M Bakker; M T Roos; M Prins; F de Wolf; R A Coutinho; F Miedema; J Goudsmit; H Schuitemaker Journal: Ann Intern Med Date: 1997-11-15 Impact factor: 25.391
Authors: Matthew J Dolan; Hemant Kulkarni; Jose F Camargo; Weijing He; Alison Smith; Juan-Manuel Anaya; Toshiyuki Miura; Frederick M Hecht; Manju Mamtani; Florencia Pereyra; Vincent Marconi; Andrea Mangano; Luisa Sen; Rosa Bologna; Robert A Clark; Stephanie A Anderson; Judith Delmar; Robert J O'Connell; Andrew Lloyd; Jeffrey Martin; Seema S Ahuja; Brian K Agan; Bruce D Walker; Steven G Deeks; Sunil K Ahuja Journal: Nat Immunol Date: 2007-10-21 Impact factor: 25.606
Authors: M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien Journal: Science Date: 1996-09-27 Impact factor: 47.728
Authors: S Mummidi; S S Ahuja; E Gonzalez; S A Anderson; E N Santiago; K T Stephan; F E Craig; P O'Connell; V Tryon; R A Clark; M J Dolan; S K Ahuja Journal: Nat Med Date: 1998-07 Impact factor: 53.440
Authors: C B Davis; I Dikic; D Unutmaz; C M Hill; J Arthos; M A Siani; D A Thompson; J Schlessinger; D R Littman Journal: J Exp Med Date: 1997-11-17 Impact factor: 14.307
Authors: Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja Journal: Curr Opin HIV AIDS Date: 2010-11 Impact factor: 4.283
Authors: Hemant Kulkarni; Brian K Agan; Vincent C Marconi; Robert J O'Connell; Jose F Camargo; Weijing He; Judith Delmar; Kenneth R Phelps; George Crawford; Robert A Clark; Matthew J Dolan; Sunil K Ahuja Journal: PLoS One Date: 2008-09-08 Impact factor: 3.240
Authors: Gabriel Catano; Hemant Kulkarni; Weijing He; Vincent C Marconi; Brian K Agan; Michael Landrum; Stephanie Anderson; Judith Delmar; Vanessa Telles; Li Song; John Castiblanco; Robert A Clark; Matthew J Dolan; Sunil K Ahuja Journal: PLoS One Date: 2008-11-04 Impact factor: 3.240
Authors: Hemant Kulkarni; Vincent C Marconi; Brian K Agan; Carole McArthur; George Crawford; Robert A Clark; Matthew J Dolan; Sunil K Ahuja Journal: PLoS One Date: 2008-11-07 Impact factor: 3.240